Skip to content

Unveiling the antiviral mechanism of A4S7: a synthetic antimicrobial peptide targeting dengue and other mosquito-borne enveloped virus infections.

Sep 2026 · Antiviral Research · Vol 255, pp. 106546 · 0 citations · 48 references
Medicine

TL;DR

The synthetic AMP A4S7 was investigated, which effectively inhibited DENV-2 RNA and protein expression and reduced viral progeny production at specified concentrations without exhibiting cytotoxicity in Vero cells, and found the α-helical structure of A4S7 was found to be crucial for its antiviral activity.

Abstract

Dengue virus (DENV), an enveloped mosquito-borne flavivirus, is the causative agent of dengue and prevalent in tropical and subtropical regions. Severe cases can progress to dengue hemorrhagic fever or shock syndrome, posing significant public health challenges. In the absence of specific antiviral drugs, antimicrobial peptides (AMPs) have emerged as promising therapeutic agents against DENV due to their broad-spectrum antibacterial and antiviral properties. This study investigated the synthetic AMP A4S7, which effectively inhibited DENV-2 RNA and protein expression and reduced viral progeny production at specified concentrations without exhibiting cytotoxicity in Vero cells. Time-of-addition assays indicated that A4S7 might exert antiviral effects during early stages of infection. Binding assays further demonstrated that A4S7 interfered with DENV-2 binding to cellular membrane receptors, supported by molecular docking and FOPPR analyses, which revealed a direct interaction between A4S7 and the DENV-2 envelope protein. Moreover, A4S7 displayed antiviral activity in DENV-2-infected human cell lines, including U2OS, HMC3, and IMR-32 cells. Notably, the α-helical structure of A4S7 was found to be crucial for its antiviral activity. Furthermore, combining A4S7 with late-stage inhibitors such as ivermectin or favipiravir resulted in superior antiviral efficacy compared with their respective monotherapies. Importantly, A4S7 also exhibited antiviral activity against other enveloped viruses, including Zika virus (ZIKV) and Sindbis virus (SINV), but showed no inhibitory effects against non-enveloped viruses such as enterovirus 71 (EV71) and adenovirus. These findings underscore the potential of A4S7 as a promising candidate for the treatment of dengue and other enveloped viral infections.

View source

Similar papers

Open access Nov 2026

Tomatidine derivatives suppress Dengue virus infection through entry and post-entry inhibition

ABSTRACT Dengue is a rapidly spreading disease transmitted by mosquitoes and is caused by the Dengue virus (DENV), affecting approximately 390 million individuals globally. Approved vaccines for use have limited efficacy, and there are no approved antivirals. Tomatidine, a steroidal alkaloid obtained from Solanum speci...

Krishnendu Das, K. Alagarasu, Diya Roy et al. · 0 citations
Review Open access Oct 2026

Antiviral Strategies Against Dengue Virus: Viral Targets, Host Pathways, and Chinese Herbal Medicines

Dengue is caused by four antigenically distinct dengue virus serotypes (DENV-1 to DENV-4) and remains a major global public health threat. It is endemic in more than 100 countries and territories, primarily in tropical and subtropical regions. According to the World Health Organization (WHO), approximately 390 million...

Qiong-Dan Liang, Kun-Peng Liu, Ming-Qing Lu et al. · 0 citations
Open access Oct 2026

Antiviral activity of HSP90 inhibitors against Mumps virus and related paramyxoviruses

Mumps virus (MuV), a member of the family Paramyxoviridae , continues to cause recurrent outbreaks worldwide despite widespread vaccination. Currently, however, no antiviral drugs have been approved for MuV or other paramyxoviruses. In this study, we screened approximately 1,000 small-molecule compounds using a r...

Fumihiro Kato, Chaewon Bae, A. Wakata et al. · 0 citations
Open access Sep 2026

Antiviral Sesquiterpene Lactones from Laurus nobilis L.: Inhibition of Hepatitis C Virus and Dengue Virus Replication

Natural products remain indispensable scaffolds in antiviral drug discovery, particularly against high-burden viral pathogens. In this study, two major sesquiterpene lactones, dehydrocostus lactone (1) and costunolide (2), were isolated from Laurus nobilis L. leaves and evaluated for their antiviral potential against h...

Yhiya M. Amen, Marwa Elsbaey, George Mpekoulis et al. · 0 citations
Oct 2026

Discovery of Indazole-Based Dual-Pharmacophore Inhibitors of Dengue and Zika Proteases as Promising Antivirals

Flavivirus outbreaks caused by dengue virus (DENV) and Zika virus (ZIKV) remain a major global health challenge, with no FDA-approved antivirals available. Herein, we designed, synthesized, and evaluated indazole-based dual pharmacophore motifs targeting NS2B-NS3 serine proteases, essential for viral replication. Enz...

S. Singh, Vijayarani Potluri, Surabhi Naza et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.